{
  "id": 18322685,
  "title": "#AASLD26: Merck unwraps biopsy data for MASH drug it got from South Korea's Hanmi",
  "url": "https://urgent.news/2026/11/05/aasld26-merck-unwraps-biopsy-data-for-mash-drug-it-got-from-south",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-05T15:00:22.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/aasld26-merck-unwraps-mash-biopsy-data-for-drug-it-got-from-south-koreas-hanmi/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Merck reported Thursday its dual GLP-1/glucagon agonist cleared a mid-stage trial in the liver disease called MASH, sharing biopsy data on a drug it licensed from Hanmi Pharmaceutical in 2020 for $10 ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}